
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Jun 23
Feb 23
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreThis video originally published on TED.
Holger Hoffmann is the Chief Executive Officer of Innoplexus. He brings with him over 25 years of broad international experience in Sales, Finance, Controlling, Joint Ventures, M&A, and Operations within management holdings, family-owned companies, and large industrial corporations.
Holger has the rare combination of experience in finance and sales, and due to his multilingual capability and genuine interest in diverse cultures and has developed excellent global business relationships.
Prof. Dr. Dr. Juergen Scheele is the Chief Medical Officer at Innoplexus and SVP Drug Development. He brings in over 20+ years of expertise in drug development and discovery. Prior to joining Innoplexus, Jürgen has held various senior positions such as Merck Global Clinical Development Leader for Tepotinib and other molecules, Global Development Leader at Roche Basel and Medical Director Micromet/ Amgen.
Jürgen has an extensive research background having received a PhD in Biochemistry / Molecular Biology from UC San Diego and the Salk Institute as well as a Master of Science in Chemistry from UC San Diego.
Werner is the SVP – Translational Science at Innoplexus. He brings more than 28 years of expertise, primarily in early stage clinical development, biomarkers, bioimaging and drug safety evaluation.
His key expertise lies in clinical and pre-clinical studies for autoimmune diseases, cardiovascular, respiratory and renal indications as well as all kinds of ligand-binding assay development, validation and application.
Werner is an MD from Goethe University, Germany.
Gaurav Tripathi is a serial entrepreneur, co-founder, and Member of the Executive Board at Innoplexus AG and Board Member at Amrit AG
He studied at IIT Bombay and has 18+ years of experience across multiple startups working in Video, Big Data, Blockchain, and AI. He co-founded Innoplexus, now known as the “German AI champion in Life Sciences” working with top 30 Pharma companies globally. As CTO, he led the team to build an IP portfolio of 145+ patents (US/EU) in areas around AI, out of which 45 have him as an inventor.
Gaurav enjoys trekking, traveling, reading, and mentoring aspiring entrepreneurs and emerging startups.
Gunjan is the Founder of Innoplexus and led the company as its CEO until 31st October 2022. He is an adjunct professor at Frankfurt School of Finance and management and Pforzheim University, Germany. He is an Ex BCG, EY who studied at IIT Bombay, MIT, Pforzheim University and European Business School. He has 18+ patents related to AI & Blockchain.
He published 2 books in Branding and Drug Discovery respectively as well as a number of publications in Harvard Business Review, Journal of Service Research, MIT Sloan Review etc. He received several awards including Capital – 40 under 40 award for Young Elite Award, Handelsblatt – BCG “Future Leaders of the new Reality“ and Top 30 “Thought Leader“ Award, Germany.
Ruben King-Shaw Jr. has over three decades of executive leadership experience in the healthcare technology and private equity sectors and has held C-suite positions with leading private companies. He is a Chief Strategy Officer and Member of the Executive Committee of the Board of Steward Health, LLC since 2018. He is also a Chief executive officer of Mansa Equity Partners, Inc., a private equity and investment advisory firm specializing in supporting the growth of healthcare companies.
Mr. King-Shaw served on the Obama Administration’s Medicare Program Advisory and Oversight Committee.
Accomplished leader with over 40 years of successful experience in global business management. Demonstrated ability of revenue generation while promoting business strategy on an international basis – largely based in Europe.
Initially, nominated by the Ministry of Commerce, Government of India as India’s Representative to UNITED NATIONS-IPS, Paris and Zurich and since 1993, Director, Europe, CII, Cologne, Germany. Since 2004, Managing Director, Europe, Reliance Europe. Leadership Coach & Cross-Cultural Trainer noted for establishing team synergies.
Ranjeet, an alumnus of the prestigious ILS Law College Pune, established a Pune-based corporate law practice known for global standards. Specializing in business disputes, real estate, and investment transactions, he is the preferred counsel for Tier-1 law firms and large corporations in Pune. Known for his practical solutions, Ranjeet handles high-profile investigations, including disciplinary actions, data breaches and corporate criminality issues. His passion for mentoring start-ups shows through successful funding transactions and incubation efforts. He is a Partner at SRB-OJAS, one of the most renowned law firms in Pune. Advising Innoplexus for a decade, his privacy and healthcare law expertise drives positive change through social impact projects, particularly in rural healthcare.
Mr. Bhatt holds dual Masters of Law (LL.M.)from New York University, USA & National University of Singapore and is a member of the prestigious Supreme Court Bar Association and Delhi High Court Bar Association. His office caters to varied clients comprising Governmental and Non-Governmental Bodies, Multinationals, Financial Institutions and individuals in an array of matters.
Mr Bhatt besides being a practicing Advocate is also a prolific speaker at various platforms and is an individual with firm belief in greater societal good. He has a keen interest in teaching and mentoring young minds and is an advisory board member to various organizations.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | The cookies are used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is used to store whether or not a user has consented to the use of cookies. It does not store any personal data. |